Anavex Life Sciences Corp.
A2-73 as a therapeutic for insomnia, anxiety, and agitation

Last updated:

Abstract:

A2-73 is a useful therapeutic in the treatment of humans suffering from insomnia, anxiety or agitation. Particular attention is made to oral daily doses of from about 10 mg to about 50 mg, with particular reference to about 20 to 30 mg.

Status:
Grant
Type:

Utility

Filling date:

27 Jul 2017

Issue date:

24 May 2022